Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 63590-64-7
Drug Levels and Effects
Summary of Use during Lactation
Because no information is available on the use of terazosin during breastfeeding, an alternate drug may be preferred, especially while nursing a newborn or preterm infant.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information in nursing mothers was not found as of the revision date. However, the pharmacologically similar drug prazosin does not affect serum prolactin concentration in patients with hypertension.[1,2] The prolactin level in a mother with established lactation may not affect her ability to breastfeed.
References
- 1.
- Barbieri C, Caldara R, Ferrari C, et al. Metabolic effects of prazosin. Clin Pharmacol Ther. 1980;27:313–6. [PubMed: 6102000]
- 2.
- Barbieri C, Ferrari C, Borzio M, et al. Metabolic effects of chronic prazosin treatment. Horm Metab Res. 1980;12:331–4. [PubMed: 6105121]
Substance Identification
Substance Name
Terazosin
CAS Registry Number
63590-64-7
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- PubMedLinks to PubMed
- Review Prazosin.[Drugs and Lactation Database (...]Review Prazosin.. Drugs and Lactation Database (LactMed®). 2006
- Review Dantrolene.[Drugs and Lactation Database (...]Review Dantrolene.. Drugs and Lactation Database (LactMed®). 2006
- Review Doxazosin.[Drugs and Lactation Database (...]Review Doxazosin.. Drugs and Lactation Database (LactMed®). 2006
- Review Moexipril.[Drugs and Lactation Database (...]Review Moexipril.. Drugs and Lactation Database (LactMed®). 2006
- Review Etodolac.[Drugs and Lactation Database (...]Review Etodolac.. Drugs and Lactation Database (LactMed®). 2006
- Terazosin - Drugs and Lactation Database (LactMed®)Terazosin - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...